Anning P B, Grocott-Mason R M, Lewis M J
Department of Pharmacology & Therapeutics, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom.
Endothelium. 1997;5(4):265-75. doi: 10.3109/10623329709052591.
ACE inhibitors exert both acute and chronic beneficial effects on cardiac function (e.g remodelling, diastolic dysfunction). We have previously reported that the ACE inhibitor captopril induces selective left ventricular (LV) relaxant effects in the isolated ejecting guinea pig heart. The aim of the present study was to further investigate the mechanism of the captopril-induced changes in early LV relaxation by comparing the effects of two sulphydryl and two non-sulphydryl containing ACE inhibitors in the same experimental preparation. Isolated ejecting guinea pig hearts were studied under conditions of constant loading and heart rate. LV pressure was monitored by a 2F micromanometer-tipped catheter transducer inserted in the LV cavity. The sulphydryl-containing ACE inhibitors captopril and zofenaprilat enhanced early LV relaxation, whereas the non-sulphydryl-containing ACE inhibitors lisinopril and quinaprilat did not. The effects of captopril and zofenaprilat were attenuated both by the nitric oxide-scavenger haemoglobin and the bradykinin B2-kinin receptor antagonist HOE 140. Neither the oxygen free-radical scavenger superoxide dismutase nor the sulphydryl-containing compound N-acetyl cysteine administered together with lisinopril had any effect on LV relaxation. These data demonstrate that inhibition of intra-cardiac ACE activity may acutely modulate LV relaxation through increased activity of the bradykinin-nitric oxide pathway. The presence of a sulphydryl group on the relevant ACE inhibitor appears to be essential for this LV relaxant effect.
血管紧张素转换酶(ACE)抑制剂对心脏功能具有急性和慢性有益作用(如重塑、舒张功能障碍)。我们之前报道过,ACE抑制剂卡托普利在离体射血豚鼠心脏中可诱导选择性左心室(LV)舒张作用。本研究的目的是通过比较两种含巯基和两种不含巯基的ACE抑制剂在同一实验制剂中的作用,进一步研究卡托普利诱导左心室早期舒张变化的机制。在恒定负荷和心率条件下研究离体射血豚鼠心脏。通过插入左心室腔的2F微测压导管传感器监测左心室压力。含巯基的ACE抑制剂卡托普利和佐芬普利拉可增强左心室早期舒张,而不含巯基的ACE抑制剂赖诺普利和喹那普利拉则无此作用。卡托普利和佐芬普利拉的作用均被一氧化氮清除剂血红蛋白和缓激肽B2受体拮抗剂HOE 140减弱。与赖诺普利一起给予的氧自由基清除剂超氧化物歧化酶和含巯基化合物N-乙酰半胱氨酸对左心室舒张均无影响。这些数据表明,抑制心脏内ACE活性可能通过增加缓激肽-一氧化氮途径的活性来急性调节左心室舒张。相关ACE抑制剂上存在巯基似乎对这种左心室舒张作用至关重要。